[
  {
    "ts": null,
    "headline": "My Top 15 High-Growth Dividend Stocks For March 2025",
    "summary": "Discover the top 15 dividend growth stocks for March 2025, offering 1.13% yield & undervalued by 25%.",
    "url": "https://finnhub.io/api/news?id=549660792df325181ad268cc1007b3dd351aa3a240c9ea997136cdd29b017e04",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741019679,
      "headline": "My Top 15 High-Growth Dividend Stocks For March 2025",
      "id": 132968538,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2156211986/image_2156211986.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "Discover the top 15 dividend growth stocks for March 2025, offering 1.13% yield & undervalued by 25%.",
      "url": "https://finnhub.io/api/news?id=549660792df325181ad268cc1007b3dd351aa3a240c9ea997136cdd29b017e04"
    }
  },
  {
    "ts": null,
    "headline": "Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up",
    "summary": "IART delivers better-than-expected earnings in the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=4994bd0760ef17a46c5974070b8cdf2585ac8d8ce858c0d656cf56425a26e3ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741010700,
      "headline": "Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up",
      "id": 133103722,
      "image": "https://media.zenfs.com/en/zacks.com/3362ed22cc614a3399ba4e9741c90266",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "IART delivers better-than-expected earnings in the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=4994bd0760ef17a46c5974070b8cdf2585ac8d8ce858c0d656cf56425a26e3ea"
    }
  },
  {
    "ts": null,
    "headline": "AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises",
    "summary": "Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.",
    "url": "https://finnhub.io/api/news?id=df59f8607e298b192c6a68bc1931722a37547392c6c37fee8dadf08cf50221e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741000440,
      "headline": "AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises",
      "id": 133103724,
      "image": "https://media.zenfs.com/en/zacks.com/d769244826e4f3d020ba08280de24d8a",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.",
      "url": "https://finnhub.io/api/news?id=df59f8607e298b192c6a68bc1931722a37547392c6c37fee8dadf08cf50221e7"
    }
  }
]